This correlation was corroborated in five murine models of psoriasis-like skin disease based on topical imiquimod application and IL-17A overexpression under different promotors, in which the elevation of NLR — but not PLR — appeared to reflect severity and early-onset of psoriatic inflammation. Here, IL17A is linked to psoriasis.